Your browser doesn't support javascript.
loading
Use of heat-not-burn tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers
Shohei Yamamoto; Akihito Tanaka; Norio Ohmagari; Koushi Yamaguchi; Kazue Ishitsuka; Naho Morisaki; Masayo Kojima; Akihiko Nishikimi; Haruhiko Tokuda; Manami Inoue; Shiori Tanaka; Jun Umezawa; Ryo Okubo; Kunihiro Nishimura; Maki Konishi; Kengo Miyo; Tetsuya Mizoue.
Afiliação
  • Shohei Yamamoto; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  • Akihito Tanaka; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan
  • Norio Ohmagari; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
  • Koushi Yamaguchi; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan
  • Kazue Ishitsuka; Department of social science, National Research Institute for Child Health and Development, Tokyo, Japan
  • Naho Morisaki; Department of social science, National Research Institute for Child Health and Development, Tokyo, Japan
  • Masayo Kojima; Department of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan
  • Akihiko Nishikimi; Biosafety Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan
  • Haruhiko Tokuda; Bioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan
  • Manami Inoue; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  • Shiori Tanaka; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  • Jun Umezawa; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  • Ryo Okubo; Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan
  • Kunihiro Nishimura; Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan
  • Maki Konishi; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  • Kengo Miyo; Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan
  • Tetsuya Mizoue; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21267032
ABSTRACT
BackgroundThe effect of heat-not-burn (HNB) tobacco product use and moderate alcohol drinking on immunogenicity to coronavirus disease (COVID-19) vaccines remain elusive. This study aimed to examine the association of tobacco product use and alcohol consumption with anti-SARS-CoV-2 spike IgG antibody titers after the BNT162b2 vaccine. MethodsParticipants were 3,457 fully vaccinated healthcare workers in the 4 national centers for advanced medical and research in Japan. Smoking status and alcohol consumption were assessed via a questionnaire, and anti-SARS-CoV-2 spike IgG titers were measured by chemiluminescent enzyme immunoassay using serum collected on the median of 64 days after the second vaccination. Multilevel linear regression models were used to estimate the geometric mean titers (GMT) and the ratios of means (RoM) between groups. ResultsOf vaccinated participants, 99.5% (3,440/3,457) were seropositive. Compared with never-smokers (GMT=119), IgG antibody titers were significantly lower among HNB tobacco users (including those who also smoked cigarettes) (GMT=105; RoM=0.88 [95%CI 0.78-0.99]) and exclusive cigarettes smokers (GMT=96; RoM=0.81 [95%CI 0.71-0.92]). Compared with non-drinkers of alcohol (GMT=123), alcohol drinkers consuming <1 go/day (GMT=114; RoM=0.93 [95%CI 0.88-0.98]), 1-1.9 go/day (GMT=105; RoM=0.85 [95%CI 0.79-0.93]), and [≥]2 go/day (GMT=101; RoM=0.82 [95%CI 0.72-0.94]) had significantly lower antibody titers (P for trend<0.01). Spline analysis showed a large reduction of antibody until around 1 go/day of alcohol consumption, and then they gradually decreased. ConclusionsResults suggest that in addition to conventional cigarette smoking and heavy alcohol drinking, use of HNB tobacco products and moderate alcohol drinking may be predictors of lower immunological response to COVID-19 vaccine. Key MessagesO_LIEpidemiological evidence regarding the association of smoking status and alcohol drinking with COVID-19 vaccine-induced antibody levels is scarce. C_LIO_LIUsers of heat-not-burn (HNB) tobacco products, as well as cigarettes smokers, had lower antibody titers than never-smokers. C_LIO_LINot only high-dose but moderate-dose alcohol intake was also associated with decreased vaccine-induced antibody levels. C_LIO_LIHNB tobacco product use and moderate alcohol drinking may be modifiers of COVID-19 vaccine-induced immunogenicity. C_LI
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...